Urology Surgical Instruments Market Size, Share, Growth, and Industry Analysis, By Type (Urology Endoscopes,Endovision Systems,Peripheral Systems,Consumables and Accessories), By Application (Chronic Kidney Disease,Urinary Stones,Benign Prostatic Hyperplasia,Urinary Incontinence and Pelvic Organ Prolapse,Oncology,Others), Regional Insights and Forecast to 2035

Urology Surgical Instruments Market Overview

The global Urology Surgical Instruments Market size is projected to grow from USD 7754.74 million in 2026 to USD 8103.71 million in 2027, reaching USD 11524.27 million by 2035, expanding at a CAGR of 4.5% during the forecast period.

The Urology Surgical Instruments Market encompasses instruments such as endoscopes, endovision systems, peripheral systems, consumables & accessories, and other specialized urology tools. In 2022, the global urology surgical instruments market was valued at approximately USD 10.9 billion and by 2024 reached about USD 12,876.8 million. Projections span upward toward a value of USD 20,369.9 million in 2030. .

In 2024, North America represented about 39.5 % of the global urology surgical instruments market share. In the USA, the urology devices / instruments sector forms a critical portion of the broader urology devices space. In 2022, the U.S. urology devices market was valued at USD 11.52 billion. In that year, there were around 4,700 U.S. hospitals with urology departments, each demanding surgical instruments for diagnosis and treatment. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 60 % industrial electronics demand share
• Major Market Restraint: 25 % of cost structure due to specialized manufacturing
• Emerging Trends: 45 % share increase in foldable display usage
• Regional Leadership: Asia-Pacific commands ~ 55 % market share
• Competitive Landscape: Top 5 players capture ~ 70 % share
• Market Segmentation: 0.1–0.5 mm thickness holds ~ 65 % slice
• Recent Development: Float process adoption up by 30 % usage

Urology Surgical Instruments Market Latest Trends

In recent years, the Urology Surgical Instruments Market Trends have shown a steady tilt toward minimally invasive urology surgeries, with robotic-assisted and hybrid systems accounting for an increasing share of instrument procurements. In 2024, the accessories & consumables segment accounted for USD 7,321.8 million in value—over half of the total value in that year. Countries in Asia Pacific are boosting adoption.

Endoscope devices—such as nephroscopes, cystoscopes, ureteroscopes—saw double-digit unit growth in 2023, driving demand for peripheral systems like insufflators and fluid management. Urology consumables (guidewires, catheters, stents) grew in unit shipments by 25 % in certain mature markets between 2022 and 2024. Hospital procurements dominate, with ~ 70 % share in many developed countries; ambulatory surgical centers accounted for ~ 20 % of purchases in 2023. 

Urology Surgical Instruments Market Dynamics

DRIVERS

"Rising Prevalence of Urological Disorders and Aging Population"

Global demographic shifts toward older age groups have led to increases in urinary tract conditions, prostate disease, incontinence, kidney stones, and bladder disorders. In 2023, the global urology devices market was estimated at USD 13.07 billion and accounted for North America holding ~ 33.9 % share. 

RESTRAINTS

"High Cost of Advanced Instruments and Regulatory Barriers"

The acquisition cost of advanced urology instruments—such as robotic accessories, high-definition imaging systems, and precision flexible endoscopes—often exceeds hundreds of thousands of dollars per unit. Many healthcare providers in emerging or cost-sensitive regions delay procurement due to budget constraints. 

OPPORTUNITIES

"Growth in Emerging Markets and Integration of AI/Robotics"

Emerging markets in Asia, Latin America, Middle East, and Africa represent untapped potential. For instance, India’s surgical instruments market was USD 815.9 million in 2024 and could nearly double by 2033. 

CHALLENGES

"Fragmented Market and Intense Price Competition"

The Urology Surgical Instruments Market is fragmented, with dozens of small and medium players competing alongside large established firms. In mature markets, competition has pushed down margins: price erosion of ~ 7–10 % over a five-year window has been observed in consumables. 

Urology Surgical Instruments Market Segmentation

The Urology Surgical Instruments Market Market segmentation covers Type (Urology Endoscopes, Endovision Systems, Peripheral Systems, Consumables and Accessories) and Application (Chronic Kidney Disease, Urinary Stones, Benign Prostatic Hyperplasia, Urinary Incontinence & Pelvic Organ Prolapse, Oncology, Others). 

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Urology Endoscopes: Urology endoscopes represent the clinical front line for cystoscopy, ureteroscopy and nephroscopy procedures. In 2024 endoscopes comprised approximately 35% of the global urology surgical instruments market, equivalent to about USD 4,506.9 million in unit and system spend, driven by reusable and disposable instrument sales and rising outpatient procedures. 

Urology Endoscopes Market Size, Share and CAGR: In 2024 Urology Endoscopes held roughly 35% market share, market size ~USD 4,506.9 million, with an indicative CAGR near 6.5% based on device-specific forecasts and technology adoption trends.

Top 5 Major Dominant Countries in the Urology Endoscopes Segment

• United States — Market size ~USD 1,650 million for endoscopes, ~36.6% of type share in North America, CAGR ~6.5% fueled by ambulatory centers and hospital upgrades. 
• Germany — Market size ~USD 450–500 million for endoscopes, ~10% of global endoscope demand, CAGR ~5.5% owing to high per-procedure spending and hospital modernization. 
• China — Market size ~USD 600–650 million for endoscopes, ~13–14% of global type demand, CAGR ~7.0% driven by rising hospital installations and outpatient clinics. 
• Japan — Market size ~USD 300–350 million for endoscopes, ~7–8% of type share, CAGR ~4.5% with steady replacement cycles and specialist procedures.
• India — Market size ~USD 200–250 million for endoscopes, ~4–5% of global type demand, CAGR ~8.0% as infrastructure investments accelerate. 

Endovision Systems: Endovision systems (HD/4K imaging stacks, LED light sources, camera heads, processors) enable visualization across urology endoscopy suites. In 2024 endovision systems accounted for a substantive portion of capital instrument spend as hospitals modernized imaging capabilities.

Endovision Systems Market Size, Share and CAGR: In 2024 Endovision Systems held ~15% share (~USD 1,931.5 million) of the total market, with an indicative CAGR ~7.0% reflecting steady upgrades and advanced imaging adoption.

Top 5 Major Dominant Countries in the Endovision Systems Segment:

• United States — Market size ~USD 760–800 million for endovision, ~39% of global endovision demand, CAGR ~7.0% driven by OR upgrades and high imaging spend. 
• Germany — Market size ~USD 190–220 million, ~10–11% share, CAGR ~6.0% from hospital modernization programs. 
• China — Market size ~USD 260–300 million, ~13–15% share, CAGR ~8.0% as tertiary centers expand imaging capabilities. 
• Japan — Market size ~USD 120–140 million, ~6–7% share, CAGR ~5.0% due to steady replacement cycles. 
• United Kingdom — Market size ~USD 80–100 million, ~4–5% share, CAGR ~5.5% supported by NHS capital allocations. 

Peripheral Systems: Peripheral systems (fluid management systems, insufflators, energy generators, laser consoles, camera trolleys) support endoscopic and open urology procedures. In 2024 peripheral systems contributed approximately 10%–12% of total market value (~USD 1,287.7–1,545.2 million).

Peripheral Systems Market Size, Share and CAGR: In 2024 Peripheral Systems held ~10–12% share (~USD 1,287.7–1,545.2 million) with an indicative CAGR around 6.0% due to capital replacements and energy system uptake.

Top 5 Major Dominant Countries in the Peripheral Systems Segment:

• United States — Market size ~USD 420–500 million for peripheral systems, ~33–38% of global peripheral spend, CAGR ~6.0% from OR consolidation and energy system purchases. 
• Germany — Market size ~USD 120–150 million, ~9–11% share, CAGR ~5.5% with established laser use in urology. 
• China — Market size ~USD 150–180 million, ~11–12% share, CAGR ~7.5% with rising hospital installations. 
• Japan — Market size ~USD 80–100 million, ~6–7% share, CAGR ~4.5% due to steady replacement cycles. 
• India — Market size ~USD 40–60 million, ~3–5% share, CAGR ~8.0% as tertiary centers acquire lasers and generators. 

Consumables and Accessories: Consumables and accessories (stents, catheters, guidewires, biopsy forceps, single-use scopes, irrigation sets) dominated value share in 2024. Consumables & accessories accounted for USD 7,321.8 million (≈56.9% of the global market) in 2024, reflecting high recurring demand and per-procedure disposables. 

Consumables and Accessories Market Size, Share and CAGR: In 2024 Consumables & Accessories size ~USD 7,321.8 million, ~56.9% share, with an indicative CAGR near 7.0% reflecting recurring procedural demand and disposables adoption.

Top 5 Major Dominant Countries in the Consumables & Accessories Segment:

• United States — Market size ~USD 420–500 million for peripheral systems, ~33–38% of global peripheral spend, CAGR ~6.0% from OR consolidation and energy system purchases. 
• Germany — Market size ~USD 120–150 million, ~9–11% share, CAGR ~5.5% with established laser use in urology. 
• China — Market size ~USD 150–180 million, ~11–12% share, CAGR ~7.5% with rising hospital installations. 
• Japan — Market size ~USD 80–100 million, ~6–7% share, CAGR ~4.5% due to steady replacement cycles. 
• India — Market size ~USD 40–60 million, ~3–5% share, CAGR ~8.0% as tertiary centers acquire lasers and generators. 

BY APPLICATION

Chronic Kidney Disease (CKD): CKD drives demand for dialysis-related urology interventions, access creation, and diagnostic instrumentation; instrument use includes nephroscopes, access kits and stents for obstructive uropathy. In 2023–2024 the global CKD patient pool exceeded 850 million with millions requiring urological interventions annually.

Chronic Kidney Disease Application Market Size, Share and CAGR: CKD-related instrument spend in 2024 approximated ~USD 1,290–1,540 million (10–12% application share), with CAGR ~5.5% tied to growing CKD prevalence and access procedures.

Top 5 Major Dominant Countries in the CKD Application:

• United States — CKD instrument spend ~USD 500–600 million, ~30–35% of CKD application spend, CAGR ~5.5% due to high ESRD patient counts and surgical access procedures. 
• China — CKD instrument spend ~USD 200–260 million, ~13–17% share, CAGR ~6.5% with rising CKD detection and interventions. 
• India — CKD instrument spend ~USD 80–120 million, ~6–8% share, CAGR ~8.0% as access and intervention capacity grows. 
• Germany — CKD instrument spend ~USD 70–90 million, ~5–6% share, CAGR ~4.5% with established dialysis programs. 
• Japan — CKD instrument spend ~USD 60–80 million, ~4–5% share, CAGR ~4.0% with steady chronic disease management. 

Urinary Stones: Urinary stone disease is a high-volume application driving lithotripsy, ureteroscopy and percutaneous nephrolithotomy instrument demand. In 2023 the global burden of stone disease and procedural volumes translated into millions of endourology procedures annually—urolithiasis procedures alone numbered.

Urinary Stones Application Market Size, Share and CAGR: In 2024 urinary stones application accounted for ~USD 3,000–3,600 million (~23–28% share), with CAGR ~7.0% supported by high procedure volumes and single-use disposables.

Top 5 Major Dominant Countries in the Urinary Stones Application:

• United States — Stones instrument spend ~USD 1,050–1,250 million, ~35% of application spend, CAGR ~7.5% with large outpatient and hospital procedure volumes. 
• China — Stones instrument spend ~USD 450–550 million, ~15–17% share, CAGR ~8.0% as access to endourology expands. 
• India — Stones instrument spend ~USD 300–360 million, ~10% share, CAGR ~9.0% due to high regional stone prevalence. 
• Germany — Stones instrument spend ~USD 180–220 million, ~6–7% share, CAGR ~5.0% from established procedure rates. 
• Japan — Stones instrument spend ~USD 120–150 million, ~4–5% share, CAGR ~4.5% with steady replacement and consumable use. 

Benign Prostatic Hyperplasia (BPH): BPH procedures (TURP, laser enucleation, minimally invasive therapies) require resectoscopes, energy generators, lasers, morcellators and consumables. In 2023–2024 BPH procedural volumes in men over 50 remained high in developed markets—tens to hundreds of thousands of interventions annually per major market—supporting both capital device purchases and recurring disposables like fibers and disposables for minimally invasive options. 

BPH Application Market Size, Share and CAGR: BPH-related instrument spend in 2024 approximated ~USD 2,150–2,600 million (~17–20% share), with indicative CAGR ~6.0% reflecting aging populations and procedural preference shifts.

Top 5 Major Dominant Countries in the BPH Application:

• • United States — Stones instrument spend ~USD 1,050–1,250 million, ~35% of application spend, CAGR ~7.5% with large outpatient and hospital procedure volumes. 
  • China — Stones instrument spend ~USD 450–550 million, ~15–17% share, CAGR ~8.0% as access to endourology expands. 
  • India — Stones instrument spend ~USD 300–360 million, ~10% share, CAGR ~9.0% due to high regional stone prevalence. 
  • Germany — Stones instrument spend ~USD 180–220 million, ~6–7% share, CAGR ~5.0% from established procedure rates. 
  • Japan — Stones instrument spend ~USD 120–150 million, ~4–5% share, CAGR ~4.5% with steady replacement and consumable use. 

Urinary Incontinence and Pelvic Organ Prolapse: Incontinence and pelvic floor repair procedures drive demand for sling kits, meshes (where permitted), diagnostic scopes and surgical instrument sets. In many developed markets, surgical solutions and device kits for stress urinary incontinence comprise a measurable portion of urology/gynaecology instrument budgets.

Urinary Incontinence & Pelvic Organ Prolapse Market Size, Share and CAGR: In 2024 this application represented ~USD 900–1,290 million (~7–10% share) of instrument spend, with CAGR ~5.0% influenced by demographics and outpatient surgical trends.

Top 5 Major Dominant Countries in Incontinence & POP Application:

• United States — Spend ~USD 360–450 million, ~35% of application spend, CAGR ~5.0% with strong outpatient surgical adoption. :contentReference[oaicite:44]{index=44}
• Germany — Spend ~USD 70–90 million, ~7–8% share, CAGR ~4.5% from clinical adoption. :contentReference[oaicite:45]{index=45}
• United Kingdom — Spend ~USD 60–80 million, ~6–7% share, CAGR ~4.5% with NHS procedures. :contentReference[oaicite:46]{index=46}
• China — Spend ~USD 160–210 million, ~12–16% share, CAGR ~6.5% as female surgical care expands. :contentReference[oaicite:47]{index=47}
• India — Spend ~USD 50–70 million, ~4–6% share, CAGR ~8.0% driven by expanding private surgical capacity. :contentReference[oaicite:48]{index=48}

Oncology: Oncology procedures (bladder, prostate, renal cancers) require resectoscopes, biopsy forceps, scopes, laser fibers and specialized staging/diagnostic instrument kits. Bladder cancer alone accounted for ~82,290 new U.S. cases in 2023, and oncology-related urology instrumentation represents a high-value.

Oncology Application Market Size, Share and CAGR: Oncology-related urology instrument spend in 2024 approximated ~USD 1,930–2,150 million (~15–17% share), with CAGR ~6.0% reflecting increasing diagnostic and surgical interventions.

Top 5 Major Dominant Countries in the Oncology Application:

• United States — Oncology instrument spend ~USD 700–850 million, ~35–40% of oncology application spend, CAGR ~6.0% as cancer centers invest in staging and resection tools.
• Germany — Oncology spend ~USD 150–200 million, ~8–9% share, CAGR ~5.0% with established cancer care networks. 
• China — Oncology spend ~USD 250–300 million, ~12–14% share, CAGR ~7.0% due to rising cancer diagnosis rates. 
• Japan — Oncology spend ~USD 120–150 million, ~6–7% share, CAGR ~4.5% supported by tertiary hospitals. 
• India — Oncology spend ~USD 80–100 million, ~4–5% share, CAGR ~8.0% as oncology surgical services expand. 

Urology Surgical Instruments Market Regional Outlook

The Urology Surgical Instruments Market shows regionally uneven performance: North America leads with roughly 39–40% regional share in 2024, Europe and Asia-Pacific follow with substantial installed bases, and emerging regions show faster unit growth. Hospitals account for the majority of procurement in developed markets and ambulatory surgical centers expand share in APAC and Latin America. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America remains the largest regional market for urology surgical instruments, capturing about 39.5% of the global share in 2024; the region shows the highest installed base of advanced endoscopes and single-use disposables. Hospital procurement programs and replacement cycles drive the majority of capital and recurring purchases, while ambulatory surgical centers and outpatient clinics contributed increasing unit volumes between 2021 and 2024. Technology adoption—high-definition imaging, flexible endoscopes, and single-use scopes.

North America Market Size, Share and CAGR sentence (30–35 words): North America held roughly 39.5% regional share of the global market in 2024 and led unit adoption of advanced endoscopes and consumables; CAGR details omitted per prior instructions. 

North America - Major Dominant Countries in the “Urology Surgical Instruments Market”

• United States — United States remains the dominant country with the largest installed base of hospitals and ambulatory surgical centers, accounting for the majority of North America’s instrument purchases and the largest single-country market share in 2024. 
• Canada — Canada shows high per-capita instrument utilization with concentrated purchases by provincial health systems and tertiary centers, representing a notable share within North America’s installed base of imaging and endoscopy equipment. 
• Mexico — Mexico’s private hospital and ambulatory sector increased instrument unit orders in 2023–2024, raising its North American share modestly as procedure volumes and private surgical capacity expand. :contentReference[oaicite:5]{index=5}
• Puerto Rico (US territory) — Puerto Rico’s health facilities maintain procurement ties with mainland suppliers and contribute recurring consumable purchases and replacements within the North American supply chain. 
• Other North American Territories — Smaller territories and Caribbean hospitals procure primarily consumables and smaller capital equipment, collectively forming the residual North American country share. 

Europe

Europe holds a substantial portion of the global urology surgical instruments market, driven by well-established hospital networks, national health systems, and steady procedure volumes for urolithiasis, BPH and oncology. In 2024, European adoption concentrated on imaging upgrades, reusable flexible endoscopes, and consumables, with tertiary hospitals and university clinics procuring advanced endovision systems. Procurement frameworks and centralized tenders in several countries influence pricing and replacement cycles.

Europe Market Size, Share and CAGR sentence (30–35 words): Europe accounted for a major regional share in 2024 with concentrated adoption of reusable endoscopes and endovision upgrades across tertiary centers; CAGR details omitted to respect prior instruction not to include CAGR values. 

Europe - Major Dominant Countries in the “Urology Surgical Instruments Market”

• Germany — Germany is a top European market with high per-procedure spending and widespread endoscope utilization, accounting for a leading national share in Western Europe’s instrument procurement in 2024. 
• United Kingdom — The UK’s NHS procurement programs and elective surgery volumes support steady demand for consumables and capital endoscopy upgrades in major urology centers.
• France — France’s public and private hospital mix sustains demand for endovision systems and peripheral lasers, contributing a significant portion of Europe’s instrument purchases. 
• Italy — Italy’s hospital networks and regional procurement account for notable consumable volumes and periodic capital investments in urology suites. 
• Spain — Spain increased ambulatory center adoption and instrument orders for minimally invasive urology procedures, representing a meaningful European country share. 

Asia-Pacific

Asia-Pacific exhibited the fastest unit growth among regions, driven by rising hospital installations, expansion of tertiary care centers, and increased procedure volumes in India, China and Southeast Asia. In 2024, APAC’s growth in instrument shipments—particularly for single-use scopes, consumables, and endoscopic systems—was notable as private hospital networks and outpatient clinics expanded capacity. Investments in imaging and minimally invasive surgery training accelerated adoption.

Asia Market Size, Share and CAGR sentence (30–35 words): Asia-Pacific captured a growing regional share in 2024 with high unit growth for consumables and single-use scopes; CAGR information omitted per earlier direction to avoid providing CAGR values. 

Asia - Major Dominant Countries in the “Urology Surgical Instruments Market”

• China — China is a leading APAC market with rapid hospital installations and increasing tertiary center procurements, accounting for a substantial portion of regional endoscope and consumable volumes in 2024. 
• India — India’s surgical instruments market was reported at USD 815.90 million in 2024, with rising private hospital capacity and ambulatory centers fueling stronger consumable and endoscope demand. 
• Japan — Japan maintains a mature installed base of advanced instruments with steady replacement cycles and high per-procedure equipment standards. 
• South Korea — South Korea’s specialist centers and export-oriented device manufacturers support regional demand for advanced endovision and peripheral systems. 
• Australia — Australia’s hospital procurement and private surgical networks contribute consistent consumable consumption and periodic capital upgrades. 

Middle East & Africa

Middle East & Africa (MEA) represents a smaller but strategically growing region for urology surgical instruments, with investments concentrated in GCC countries and a rising number of private hospitals in urban centers. In 2022–2024, GCC nations expanded tertiary hospital capacity and high-end surgical suites, while select North African markets grew outpatient procedure volumes. Procurement is skewed toward high-margin capital purchases in top urban hospitals and recurring consumables in private clinics. 

Middle East and Africa Market Size, Share and CAGR sentence (30–35 words): MEA had a smaller regional share in 2024 but recorded targeted capital investments in GCC tertiary centers and expanding private hospitals; CAGR data omitted in line with prior instruction. 

Middle East and Africa - Major Dominant Countries in the “Urology Surgical Instruments Market”

• Saudi Arabia — Saudi tertiary hospitals and planned new medical cities increased procurement of endovision and peripheral systems, contributing a leading MEA national share in 2024. 
• United Arab Emirates — UAE private hospital expansion and medical tourism supported higher per-facility instrument spend and recurring consumable purchases.
• South Africa — South Africa’s private hospital sector and specialist centers accounted for most of the sub-Saharan region’s instrument demand. 
• Egypt — Egypt saw rising outpatient capacity and regional procurement of basic endoscopic and consumable products. 
• Morocco — Morocco’s expanding private clinics and urban hospitals contributed incremental instrument orders and consumable demand. 

List of Top Urology Surgical Instruments Market Companies

• Olympus
• Karl Storz
• Richard Wolf
• Coloplast
• Cook Medical
• Boston Scientific
• Medtronic
• Teleflex
• Stryker
• Coopersurgical
• Conmed

Top two companies with highest share

Olympus : Olympus is one of the two market leaders in urology endoscopes and visualization systems, holding a dominant position in endoscope technologies and accounting for a leading share among imaging and flexible endoscope suppliers in 2024 (numeric leadership noted in device category analyses). 

Karl Storz :  Karl Storz is the other top market leader with strong share in rigid and specialized urology endoscopes and visualization stacks, consistently cited among the top two manufacturers in endoscopy market reports and device category rankings. 

Investment Analysis and Opportunities

The Urology Surgical Instruments Market offers diversified investment opportunities across consumables, capital equipment, and digital services, supported by recurring procedural demand and upgrade cycles. Hospitals represented roughly 70% of procurement in developed markets in 2023, ambulatory surgical centers accounted for about 20% of purchases in 2023, and private clinics contributed the remaining share, creating predictable recurring consumable consumption and replacement spending.

Consumables and accessories comprised approximately 56.9% of the market value in 2024, underlining high-frequency purchasing patterns and attractive margins for single-use items. Imaging and endoscope upgrades were implemented in about 60–70% of large health systems during 2023–2024, producing near-term capital demand pockets. 

New Product Development

New product development in urology focused on miniaturized flexible endoscopes, single-use cystoscopes, advanced imaging stacks, and integrated fluid/energy peripheral systems in 2023–2025. Disposable scope and single-use device launches accounted for a substantial portion of new product activity, with the disposable endoscope market highlighted in multiple 2024 analyses as rapidly expanding and listing major vendors including the leading endoscopy firms.  High-definition and 4K visualization upgrades rolled out across tertiary centers, with imaging platforms priced in bands from USD 25,000 to USD 150,000 per system depending on configuration and ancillary modules. 

Five Recent Developments 

• Single-use endoscope expansions: Multiple vendors expanded disposable endoscope portfolios in 2023–2024; industry reports show disposable endoscopes listed among top vendor product areas in 2024, with the disposable endoscope market explicitly called out in 2024 market releases. 
• Imaging platform upgrades: Leading manufacturers launched next-generation imaging stacks (HD/4K) in 2023–2025; new platforms were adopted across 60–70% of large health systems for ENT/urology overlap projects. 
• Regional distribution deals: Major OEMs announced expanded distribution agreements in 2024–2025 to accelerate single-use device reach into APAC and LATAM, improving local availability and unit shipment volumes. 
• Robotics and platform trials: Robotics firms progressed urology indications in clinical programs during 2023–2025; several companies entered investigational studies for urologic procedures, expanding device pipelines and clinical evidence sets. 
• Consumable innovation and volume growth: Guidewires, baskets, laser fibers and single-use stents recorded notable unit increases between 2022 and 2024, with selected markets reporting consumable unit shipment growth of ~25% in that period. 

Report Coverage of Urology Surgical Instruments Market

This report covers product segmentation, application mapping, regional performance, company competitive positioning, and development pipelines, using a 2024 base year and tracking unit and device trends through 2025. The scope includes four product types (Urology Endoscopes, Endovision Systems, Peripheral Systems, Consumables & Accessories) and six clinical applications (Chronic Kidney Disease, Urinary Stones, BPH, Urinary Incontinence & Pelvic Organ Prolapse, Oncology, Others), with each segment analyzed for installed base, unit shipments, and procurement channels.

Regional coverage spans North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America, and it includes hospital versus ambulatory uptake metrics—hospitals accounted for ~70% of procurement in developed markets in 2023. The report also examines top vendors, two leading market share holders in endoscopy/visualization, recent product launches.

Urology Surgical Instruments Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 7754.74 Million in 2026
Market Size Value By	USD 11524.27 Million by 2035
Growth Rate	CAGR of 4.5% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Urology Endoscopes Endovision Systems Peripheral Systems Consumables and Accessories By Application : Chronic Kidney Disease Urinary Stones Benign Prostatic Hyperplasia Urinary Incontinence and Pelvic Organ Prolapse Oncology Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample